Chemoinformaics analysis of 2,4-Dimethyl-4-octanol
| Molecular Weight | 158.285 | nRot | 5 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 0 |
| Exact Molecular Weight | 158.167 | nRing | 0 |
| Solubility: LogS | -2.797 | nHRing | 0 |
| Solubility: LogP | 3.617 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 32.1714 |
| nHD | 1 | BPOL | 22.0706 |
| QED | 0.652 |
| Synth | 2.789 |
| Natural Product Likeliness | 0.75 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.2 |
| MDCK | 0.0000203 |
| BBB | 0.962 |
| PPB | 0.78754 |
| VDSS | 1.482 |
| FU | 0.23391 |
| CYP1A2-inh | 0.63 |
| CYP1A2-sub | 0.724 |
| CYP2c19-inh | 0.365 |
| CYP2c19-sub | 0.922 |
| CYP2c9-inh | 0.332 |
| CYP2c9-sub | 0.915 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.142 |
| CYP3a4-inh | 0.08 |
| CYP3a4-sub | 0.189 |
| CL | 12.163 |
| T12 | 0.445 |
| hERG | 0.022 |
| Ames | 0.004 |
| ROA | 0.015 |
| SkinSen | 0.194 |
| Carcinogencity | 0.058 |
| EI | 0.979 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.851933 |